Task: Answer the multiple-choice question.
Question: Which compound exhibits a 10.512% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) COc1ccc(Cl)cc1-c1nc(SCC(=O)N(C)C)n[nH]1
b.) CCCc1nnc(NC(=O)CCC(=O)NCc2ccc(OC)cc2)s1
c.) Cc1ccc(NC(=O)CN2C(=O)c3ccccc3C2=O)c(C)c1
Answer: a. COc1ccc(Cl)cc1-c1nc(SCC(=O)N(C)C)n[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(Cl)cc1-c1nc(SCC(=O)N(C)C)n[nH]1
COc1ccc(Cl)cc1-c1nc(SCC(=O)N(C)C)n[nH]1
2-[[5-(5-chloro-2-methoxyphenyl)-1H-1,2,4-triazol-3-yl]sulfanyl]-N,N-dimethylacetamide